DNA RNA and Cells

27 Jul 2009 MOLOGEN AG extends clinical study to include another dosing group
23 Jul 2009 miRagen and Archemix to Collaborate on Conjugated Aptamer-microRNA Therapeutics
21 Jul 2009 Archemix and Dicerna to Collaborate on Conjugated Aptamer-Dicer Substrate RNAi Therapeutics
20 Jul 2009 Alnylam and Cubist Announce Complete Data from Phase II Study of ALN-RSV01 in Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus
17 Jul 2009 Alnylam Announces Extension of RNAi Therapeutics Collaboration with Novartis
13 Jul 2009 Oxford Biomedica Announces Update On Phase I/II Study Of ProSavin® In Parkinson's Disease
10 Jul 2009 Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
09 Jul 2009 Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
02 Jul 2009 Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
24 Jun 2009 Osiris Therapeutics Reports Interim Data for COPD Stem Cell Study
24 Jun 2009 Living Cell Technologies’ Diabetes Clinical Trial Authorized by New Zealand Government
24 Jun 2009 Mesoblast Limited's (ASX:MSB) First Patients In Bone Marrow Transplant Trial Show Earlier Engraftment
22 Jun 2009 Targeted Genetics Announces Continued Clinical Study at University College London/Moorfields Eye Hospital for a Gene Therapeutic to Treat Leber's Congenital Amaurosis and Provides Business Update
18 Jun 2009 FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
18 Jun 2009 Glybera(TM) Shows Long-Term Health Benefits
18 Jun 2009 Alnylam and Collaborators Present New Pre-Clinical Research Findings on RNAi Therapeutics Targeting PCSK9, a Genetically Validated Regulator of LDL Metabolism
16 Jun 2009 Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
15 Jun 2009 Mirna Therapeutics Presents Data at Keystone Symposium on MicroRNA and Cancer
15 Jun 2009 Cenix BioScience expands relationship with AstraZeneca, signing multi-project research agreement
10 Jun 2009 Amarin Announces Results from Exploratory Phase 2a Study of EN101 in Myasthenia Gravis
09 Jun 2009 Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions
08 Jun 2009 StemCells, Inc. Announces Positive Phase I Batten Trial Results
08 Jun 2009 Alnylam and Cubist Report Preliminary Data from Phase II Study of ALN-RSV01 in Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus
08 Jun 2009 MDRNA, Inc. Reports Effective Local Delivery of a UsiRNA in an In Vivo Model of Bladder Cancer
08 Jun 2009 Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up